| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/04/1994 | US5352459 Use of purified surface modifiers to prevent particle aggregation during sterilization |
| 10/04/1994 | US5352453 Acidic ph |
| 10/04/1994 | US5352452 Anticoagulants, enzyme activity |
| 10/04/1994 | US5352447 Coupling of an diphtheria with transferrin or monoclonal antibody |
| 10/04/1994 | US5352435 Ionophore containing liposomes for ultrasound imaging |
| 10/04/1994 | CA1332235C Water insoluble derivatives of hyaluronic acid |
| 10/01/1994 | CA2119733A1 Antibody-drug conjugates |
| 10/01/1994 | CA2115907A1 Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastrointestinal tract |
| 10/01/1994 | CA2102142A1 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
| 09/30/1994 | CA2119531A1 Anti-inflammatory analgesic plaster |
| 09/29/1994 | WO1994021813A1 Monoclonal antibodies specific for fibroblast growth factor receptors, immunotoxins, and use thereof |
| 09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
| 09/29/1994 | WO1994021656A2 Novel phospholipid-saccharide conjugates |
| 09/29/1994 | WO1994021300A2 Novel agent for controlling cell activity |
| 09/29/1994 | WO1994021299A1 A composition and a method for tissue augmentation |
| 09/29/1994 | WO1994021298A1 Stabilised pharmaceutical compositions and methods for preparing same |
| 09/29/1994 | WO1994021292A1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/29/1994 | WO1994021288A1 Composition and method for reducing toxicity of biologically-active factors |
| 09/29/1994 | WO1994021281A1 Polymer-polypeptide composition and method |
| 09/29/1994 | WO1994021271A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 09/29/1994 | WO1994021268A1 Aluminium containing pharmaceutical preparation with controlled release |
| 09/29/1994 | WO1994021267A1 Tylosin containing sustained release veterinary compositions |
| 09/29/1994 | WO1994021263A1 Pharmaceutical composition in the form of a kit |
| 09/29/1994 | WO1994021240A2 Superparamagnetic particles, process for producing the same and their use |
| 09/29/1994 | WO1994021236A1 Cross-linked amylose as a binder/disintegrant in tablets |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994021233A1 Oil-in-water emulsion containing a perfluoropolyether, composition comprising same, preparation method therefor and cosmeticological and dermatological use thereof |
| 09/29/1994 | WO1994021232A1 Water dispersible therapeutic compounds |
| 09/29/1994 | WO1994021230A1 Method and compositions for disrupting the epithelial barrier function |
| 09/29/1994 | WO1994021229A1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| 09/29/1994 | WO1994021228A1 Aerosol formulation containing a diol-diacid derived dispersing aid |
| 09/29/1994 | WO1994021227A1 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 09/29/1994 | WO1994021225A1 Skin care composition |
| 09/29/1994 | WO1994021215A1 Low-viscosity cosmetic and pharmaceutical emulsions |
| 09/29/1994 | WO1994017792A3 Compositions and methods for transdermal drug delivery |
| 09/29/1994 | WO1994012220A3 Water soluble non-immunogenic polyamide cross-linking agents |
| 09/29/1994 | WO1994009826A3 Drug delivery systems, characterised by a photolabile linkage |
| 09/29/1994 | DE4410470A1 Pharmazeutische Zusammensetzungen mit analgetischer Aktivität Pharmaceutical compositions having analgesic activity |
| 09/29/1994 | CA2158655A1 Process for preparing cancer vaccines |
| 09/29/1994 | CA2158647A1 Conjugate containing botulinum toxin translocation and effector domains and heterologocus binding domain for the targeted control of cell activity |
| 09/29/1994 | CA2158437A1 Aluminium containing pharmaceutical preparation with controlled release |
| 09/29/1994 | CA2158140A1 Stabilized pharmaceutical compositions and methods for preparing same |
| 09/29/1994 | CA2158055A1 Novel phospholipid-saccharide conjugates |
| 09/29/1994 | CA2155210A1 Cross-linked amylose as a binder/disintegrant in tablets |
| 09/29/1994 | CA2136214A1 Oil-in-water emulsion containing a perfluoropolyether, composition comprising same, preparation method therefor and cosmetological and dermatological use thereof |
| 09/28/1994 | EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins |
| 09/28/1994 | EP0616814A1 Compositions for controlled release of biologically active TGF - beta |
| 09/28/1994 | EP0616813A2 Antitumor mitoxantrone polymeric compositions |
| 09/28/1994 | EP0616801A1 Process for preparing a liposome dispersion at high pressure |
| 09/28/1994 | EP0616533A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 09/28/1994 | EP0616530A1 Use of cytochalasins for inhibiting viral replication |
| 09/28/1994 | EP0616528A1 Implantable capsule |
| 09/28/1994 | EP0616527A1 Process and device for the encapsulation of a substance |
| 09/28/1994 | EP0616523A1 Medicaments |
| 09/28/1994 | EP0616508A1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | EP0507944B1 Implantable biodegradable material and method for producing same |
| 09/28/1994 | EP0468003B1 Encapsulation of active substances in starch |
| 09/28/1994 | CN1092648A Ranitidine compositions |
| 09/28/1994 | CN1026001C New esters of alginic acid |
| 09/27/1994 | US5350769 Sodium or ammonium diclofenac, a nonionic polymer, an ester of a diacid and an lower alcohol |
| 09/27/1994 | US5350584 Spheronization process using charged resins |
| 09/27/1994 | US5350582 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof |
| 09/27/1994 | US5350574 Immunosuppressive agent for preventing organ rejection |
| 09/27/1994 | US5349957 MRI diagnostic agent |
| 09/27/1994 | CA2119090A1 Compositions for controlled release of biologically active tgf-.beta. |
| 09/27/1994 | CA1332199C Process of preparing silicone composition, and cosmetic and lustering materials containing silicone composition obtained |
| 09/27/1994 | CA1332152C Pharmaceutical composition of dihydropyridine compound |
| 09/27/1994 | CA1332150C Pharmaceutical compositions comprising cyclosporins |
| 09/26/1994 | CA2119675A1 Antitumor mitoxantrone polymeric compositions |
| 09/22/1994 | DE4309415A1 Pharmaceutical product |
| 09/22/1994 | DE4309333A1 Superparamagnetic particles, process for their production and use thereof |
| 09/21/1994 | EP0615979A2 Partial esters of acidic polysaccharides |
| 09/21/1994 | EP0615754A1 Solid controlled-release administration forms containing flupertine |
| 09/21/1994 | EP0615748A1 Galenical matrices preferably in microsphere form |
| 09/21/1994 | EP0615741A1 Oil-in-water type emulsion composition |
| 09/21/1994 | EP0615446A1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation. |
| 09/21/1994 | EP0615443A1 Immediate-effect flurbiprofen-containing medicament and its use. |
| 09/21/1994 | EP0615439A1 Slow-release ibuprofen-containing medicament and its use. |
| 09/20/1994 | US5349066 Bifunctional linking compounds, conjugates and methods for their production |
| 09/20/1994 | US5349052 Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor |
| 09/20/1994 | US5349001 Cyclic imide thione activated polyalkylene oxides |
| 09/20/1994 | US5348954 Heterocyclic chelating agents |
| 09/20/1994 | US5348941 Adenosine phosphates |
| 09/20/1994 | US5348939 Fibronectin-containing ophthalmic solution, method of preserving an ophthalmic solution, and method of treatment of ophthalmic wounds |
| 09/20/1994 | US5348852 Diagnostic and therapeutic compositions |
| 09/20/1994 | US5348744 Antidiarrheal compositions containing loperamide hydrochloride and a saccharide |
| 09/20/1994 | US5348016 Apparatus for preparing gas filled liposomes for use as ultrasonic contrast agents |
| 09/20/1994 | CA1332045C Edible plastic composition |
| 09/17/1994 | WO1993018749A1 Liposomes with excess negative charge |
| 09/15/1994 | WO1994020856A1 Macromolecular microparticles and methods of production |
| 09/15/1994 | WO1994020512A2 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 09/15/1994 | WO1994020453A1 Taxol polyalkylene oxide conjugates of taxol and taxol intermediates |
| 09/15/1994 | WO1994020145A1 Use of low density lipoprotein with cytotoxic substances |
| 09/15/1994 | WO1994020143A1 Optical isomerization inhibitor |
| 09/15/1994 | WO1994020136A1 Cyclodextrin-peptide compositions |
| 09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/15/1994 | WO1994020091A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| 09/15/1994 | WO1994020089A1 Taxol-based compositions with enhanced bioactivity |
| 09/15/1994 | WO1994020087A1 Throat compositions |